Fact Source: Financial Supervisory Service DART
💡 3-Second Summary
Hanwha Aerospace signed a supply contract worth approximately KRW 166.26B with LIG Nex1 for major components and launch tubes for the Cheolmae-II PIP (Cheongung-II) 2nd mass production, representing 2.5% of its recent annual revenue.
📊 Key Disclosure Contents & Financial Figures
- Disclosure Title: Execution of Single Sales or Supply Contract
- Contract Classification: Product Supply
- Contract Title: Cheolmae-II PIP Guided Missile (2nd Mass Production) and 1 other item
- Contract Details:
- Contract Amount: KRW 166,261,527,382 (approx. KRW 166.26B)
- Recent Annual Revenue: KRW 6,539,605,817,572 (2022 consolidated basis)
- Ratio to Revenue: 2.5%
- Large Corporation Status: Yes
- Counterparty & Region:
- Contract Counterparty: LIG Nex1 (Relationship: None)
- Sales/Supply Region: Republic of Korea
- Contract Period & Key Terms:
- Contract Period: February 19, 2024 ~ May 10, 2027
- Contract (Order) Date: February 19, 2024
- Key Terms: Supply contract for major components and launch tubes for Cheolmae-II PIP (Cheongung-II) 2nd mass production guided missiles
- Other Important Matters: Contract amount and period may change during execution, and a correction disclosure will be filed if major terms are modified.
📝 Editor’s Comment (Key Follow-up Checkpoint)
📌 Verification of Contract Execution and Subsequent Correction Disclosures
This defense supply contract with LIG Nex1 spans through May 10, 2027. Monitoring whether any correction disclosures are filed regarding adjustments to the contract amount or period during the execution process is important to confirm contract progress. Detailed updates can be verified in subsequent correction filings and periodic reports.
📢 Disclaimer & Source Notice
Source: This content was newly generated and structured based on official data submitted to the Financial Supervisory Service DART.
Investment Risk Warning: This content is provided for informational and linguistic reference purposes only. Under no circumstances does it constitute financial advice or a recommendation to buy or sell specific stocks. All investment decisions and financial responsibilities rest entirely with the investor.
Contact: For compliance inquiries or copyright requests, please contact ksb220805@gmail.com.
